Daniel P. Finke - 03 Aug 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Signature
/s/ Daniel P. Finke
Issuer symbol
CVS
Transactions as of
03 Aug 2022
Transactions value $
-$454,676
Form type
4
Filing time
05 Aug 2022, 16:48:16 UTC
Previous filing
06 Apr 2022
Next filing
04 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $500K +9.55K +29.69% $52.37 41.7K 03 Aug 2022 Direct
transaction CVS Common Stock Sale -$955K -9.55K -22.89% $100.00 32.1K 03 Aug 2022 Direct F1
holding CVS Common Stock (pep) 3.12K 03 Aug 2022 Direct
holding CVS Common Stock (restricted) 15.9K 03 Aug 2022 Direct
holding CVS Stock Unit (deferred) 3.12K 03 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -9.55K -33.33% $0.00 19.1K 03 Aug 2022 Common Stock 9.55K $52.37 Direct F2
holding CVS Stock Option 16.2K 03 Aug 2022 Common Stock 16.2K $54.19 Direct F3
holding CVS Stock Option 27.2K 03 Aug 2022 Common Stock 27.2K $58.34 Direct F4
holding CVS Stock Option 82.1K 03 Aug 2022 Common Stock 82.1K $74.30 Direct F5
holding CVS Stock Option 52K 03 Aug 2022 Common Stock 52K $101.09 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in three equal annual installments, commencing 5/31/2022.
F3 Option became exercisable in four equal annual installments, beginning on 4/1/2020.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2022.
F6 Option becomes exercisable in four equal annual installments, commencing 4/1/2023.